TLSA ▲ +8.9% - Tiziana Life Sciences Ltd $TLSA - Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis 02-NOV-2026 07:00 AM ET